MedPath

Comparison the effect of melatonin plus propranolol and propranolol on the improvement of symptoms of migraine headache with sleep disorders in childre

Not Applicable
Conditions
Migraine and sleep disorders.
Migraine
Registration Number
IRCT20190619043946N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

1- Children aged 5 to 15 years
2. A definitive diagnosis of migraine disease by a neurologist.
3- Rejection of other causes of headache
4. Family consent to attend the project
5. Suitable for the onset of migraine prophylaxis: more than one attack per week, more than a disabling attack (leading to school absenteeism or dysfunction, PEDMIDAS of more than 20
6. Sleep disturbance includes: late sleep, early waking, low sleep, frequent waking up during nighttime sleep.

Exclusion Criteria

1-For any reason, patients tend to continue to study or change the diagnosis.
2- Cases of other underlying illnesses that do not have the ability to use propranolol.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Migraine. Timepoint: Patients are evaluated 1 month after treatment and in those who continue to receive treatment at the end of the first three months the rate of recovery is assessed. Method of measurement: The severity of migraine headaches is assessed using the PEDMIDAS method.;Sleep disorders. Timepoint: Patients are evaluated 1 month after treatment and in those who continue to receive treatment at the end of the first three months the rate of recovery is assessed. Method of measurement: Child Sleep Disorder will be assessed using the CSHQ Child Sleep Habits Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath